Senior insider sale
President, Oncology at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$8.34M
75.30K shares
What this filing means
VIEIRA ROBERTO WANDENKOLK plans to sell 75.30K shares of CORCEPT THERAPEUTICS INC valued at approximately $8.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001972481-26-000271
Officer· President, Oncology
Since Sep 2026
75.30K
Shares to sell
$8.34M
Approx. market value
75.30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
ESPP
Cash
9/1/2026
296.00Stock Option Exercise
Cash
2/1/2024
75KTotal acquired75.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | ESPP Cash | 296.00 | — |
2/1/2024 | Stock Option Exercise Cash | 75K | — |
| Total | 75.30K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
75.30K
Market value
$8.34M
9/2/2026
Total
Units
75.30K
Value
$8.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/2/2026 | 75.30K | $8.34M | Nasdaq | Planned |
| Total | 75.30K | $8.34M | ||